Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
7
HKD
|
+8.70%
|
|
+5.74%
|
+23.89%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
9,122
|
12,987
|
27,423
|
19,359
|
12,129
|
12,129
|
-
|
Enterprise Value (EV)
1 |
9,122
|
12,987
|
21,959
|
13,339
|
12,733
|
9,054
|
8,099
|
P/E ratio
|
5.65
x
|
-
|
10.1
x
|
4.35
x
|
16.3
x
|
9.1
x
|
7.14
x
|
Yield
|
-
|
-
|
2.8%
|
6.98%
|
2.09%
|
3.95%
|
4.85%
|
Capitalization / Revenue
|
-
|
1.08
x
|
1.41
x
|
0.85
x
|
0.81
x
|
0.62
x
|
0.57
x
|
EV / Revenue
|
-
|
1.08
x
|
1.13
x
|
0.58
x
|
0.81
x
|
0.47
x
|
0.38
x
|
EV / EBITDA
|
-
|
6.04
x
|
4.41
x
|
1.92
x
|
6.29
x
|
1.97
x
|
1.51
x
|
EV / FCF
|
-
|
-
|
-422,992,592
x
|
9,519,451
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-0%
|
0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
1.7
x
|
1.05
x
|
0.89
x
|
0.94
x
|
0.73
x
|
Nbr of stocks (in thousands)
|
2,111,689
|
2,111,689
|
2,255,190
|
2,253,689
|
1,732,712
|
1,732,712
|
-
|
Reference price
2 |
4.320
|
6.150
|
12.16
|
8.590
|
7.000
|
7.000
|
7.000
|
Announcement Date
|
3/29/20
|
3/9/21
|
3/21/22
|
3/28/23
|
3/26/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
11,980
|
19,485
|
22,868
|
15,709
|
19,471
|
21,223
|
EBITDA
1 |
-
|
2,150
|
4,975
|
6,954
|
2,026
|
4,588
|
5,351
|
EBIT
1 |
-
|
1,337
|
4,090
|
5,869
|
709.8
|
2,175
|
2,560
|
Operating Margin
|
-
|
11.16%
|
20.99%
|
25.67%
|
4.52%
|
11.17%
|
12.06%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
3,990
|
5,852
|
708
|
2,711
|
3,327
|
Net income
1 |
1,598
|
921
|
2,552
|
4,402
|
767.2
|
1,629
|
1,986
|
Net margin
|
-
|
7.69%
|
13.1%
|
19.25%
|
4.88%
|
8.37%
|
9.36%
|
EPS
2 |
0.7647
|
-
|
1.205
|
1.975
|
0.3468
|
0.7695
|
0.9808
|
Free Cash Flow
|
-
|
-
|
-51.91
|
1,401
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-0.27%
|
6.13%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
20.15%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
31.83%
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.3400
|
0.6000
|
0.1463
|
0.2763
|
0.3397
|
Announcement Date
|
3/29/20
|
3/9/21
|
3/21/22
|
3/28/23
|
3/26/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
5,464
|
6,020
|
5,287
|
3,074
|
4,030
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-51.9
|
1,401
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
19.2%
|
26.4%
|
4.37%
|
10.2%
|
10.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
10.7%
|
16.7%
|
3.35%
|
6.6%
|
6.4%
|
Assets
1 |
-
|
-
|
23,811
|
26,402
|
23,324
|
24,689
|
31,032
|
Book Value Per Share
2 |
-
|
-
|
7.170
|
8.220
|
7.820
|
7.410
|
9.570
|
Cash Flow per Share
2 |
-
|
-
|
2.210
|
2.580
|
4.200
|
1.770
|
6.430
|
Capex
1 |
-
|
-
|
4,736
|
4,356
|
3,751
|
2,197
|
2,197
|
Capex / Sales
|
-
|
-
|
24.31%
|
19.05%
|
23.56%
|
11.28%
|
10.35%
|
Announcement Date
|
3/29/20
|
3/9/21
|
3/21/22
|
3/28/23
|
3/26/24
|
-
|
-
|
Average target price
9.99
HKD Spread / Average Target +42.71% Consensus |
1st Jan change
|
Capi.
|
---|
| +23.89% | 1.55B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|